Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 80
Filter
Add more filters











Publication year range
1.
Molecules ; 22(7)2017 Jul 11.
Article in English | MEDLINE | ID: mdl-28696352

ABSTRACT

Background: Acetylcholinesterase (AChE) is an important neurotransmitter hydrolase in invertebrate and vertebrate nervous systems. The number of AChEs is various among invertebrate species, with different functions including the 'classical' role in terminating synaptic transmission and other 'non-classical' roles. Methods: Using rapid amplification of cDNA ends (RACE) technology, a new putative AChE-encoding gene was cloned from Pardosa pseudoannulata, an important predatory natural enemy. Sequence analysis and in vitro expression were employed to determine the structural features and biochemical properties of this putative AChE. Results: The cloned AChE contained the most conserved motifs of AChEs family and was clearly clustered with Arachnida AChEs. Determination of biochemical properties revealed that the recombinant enzyme had the obvious preference for the substrate ATC (acetylthiocholine iodide) versus BTC (butyrylthiocholine iodide). The AChE was highly sensitive to AChE-specific inhibitor BW284C51, but not butyrylcholinesterase-specific inhibitor tetraisopropyl pyrophosphoramide (ISO-OMPA). Based on these results, we concluded that a new AChE was identified from P. pseudoannulata and denoted as PpAChE5. Conclusion: Here we report the identification of a new AChE from P. pseudoannulata and increased the AChE number to five in this species. Although PpAChE5 had the biggest Vmax value among five identified AChEs, it showed relatively low affinity with ATC. Similar sensitivity to test insecticides indicated that this AChE might serve as the target for both organophosphorus and carbamate insecticides.


Subject(s)
Acetylcholinesterase/metabolism , Spiders/enzymology , Acetylcholinesterase/genetics , Animals , Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide/pharmacology , Butyrylcholinesterase/metabolism , Carbaryl/pharmacology , Cholinesterase Inhibitors/pharmacology , Cloning, Molecular , Humans , Insecticides/pharmacology , Paraoxon/pharmacology , Sf9 Cells , Substrate Specificity , Tetraisopropylpyrophosphamide/pharmacology
2.
Arch Toxicol ; 91(10): 3295-3305, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28299395

ABSTRACT

Phenyl valerate is used for detecting and measuring neuropathy target esterase (NTE) and has been used for discriminating esterases as potential target in hen model of organophosphorus delayed neuropathy. In previous studies we observed that phenyl valerate esterase (PVase) activity of an enzymatic fraction in chicken brain might be due to a butyrylcholinesterase protein (BuChE), and it was suggested that this enzymatic fraction could be related to the potentiation/promotion phenomenon of the organophosphate-induced delayed neuropathy (OPIDN). In this work, PVase activity of purified human butyrylcholinesterase (hBuChE) is demonstrated and confirms the novel observation that a relationship of BuChE with PVase activities is also relevant for humans, as is, therefore the potential role in toxicity for humans. The KM and catalytic constant (kcat) were estimated as 0.52/0.72 µM and 45,900/49,200 min-1 respectively. Furthermore, this work studies the inhibition by preincubation of PVase and cholinesterase activities of hBuChE with irreversible inhibitors (mipafox, iso-OMPA or PMSF), showing that these inhibitors interact similarly in both activities with similar second-order inhibition constants. Acethylthiocholine and phenyl valerate partly inhibit PVase and cholinesterase activities, respectively. All these observations suggest that both activities occur in the same active center. The interaction with a reversible inhibitor (ethopropazine) showed that the cholinesterase activity was more sensitive than the PVase activity, showing that the sensitivity for this reversible inhibitor is affected by the nature of the substrate. The present work definitively establishes the capacity of BuChE to hydrolyze the carboxylester phenyl valerate using a purified enzyme (hBuChE). Therefore, BuChE should be considered in the research of organophosphorus targets of toxicity related with PVase proteins.


Subject(s)
Butyrylcholinesterase/metabolism , Cholinesterase Inhibitors/pharmacology , Valerates/metabolism , Acetylcholine/metabolism , Carboxylic Ester Hydrolases/metabolism , Humans , Hydrolysis , Isoflurophate/analogs & derivatives , Isoflurophate/pharmacology , Phenothiazines/pharmacology , Phenylmethylsulfonyl Fluoride/pharmacology , Tetraisopropylpyrophosphamide/pharmacology
3.
Toxins (Basel) ; 7(8): 2739-56, 2015 Jul 24.
Article in English | MEDLINE | ID: mdl-26213967

ABSTRACT

Effective and ecofriendly antifouling (AF) compounds have been arising from naturally produced chemicals. The objective of this study is to use cyanobacteria-derived agents to investigate the role of acetylcholinesterase (AChE) activity as an effect and/or mode of action of promising AF compounds, since AChE inhibitors were found to inhibit invertebrate larval settlement. To pursue this objective, in vitro quantification of AChE activity under the effect of several cyanobacterial strain extracts as potential AF agents was performed along with in vivo AF (anti-settlement) screening tests. Pre-characterization of different cholinesterases (ChEs) forms present in selected tissues of important biofouling species was performed to confirm the predominance of AChE, and an in vitro AF test using pure AChE activity was developed. Eighteen cyanobacteria strains were tested as source of potential AF and AChE inhibitor agents. Results showed effectiveness in selecting promising eco-friendly AF agents, allowing the understanding of the AF biochemical mode of action induced by different compounds. This study also highlights the potential of cyanobacteria as source of AF agents towards invertebrate macrofouling species.


Subject(s)
Acetylcholinesterase/metabolism , Cholinesterase Inhibitors/pharmacology , Cyanobacteria/metabolism , Mytilus/enzymology , Thoracica/enzymology , Animals , Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide/pharmacology , Biofouling , Copper/pharmacology , Mytilus/drug effects , Physostigmine/pharmacology , Tetraisopropylpyrophosphamide/pharmacology , Thoracica/drug effects
4.
Ecotoxicology ; 23(3): 449-58, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24526590

ABSTRACT

Metals are released into freshwater ecosystems from natural and anthropogenic sources, compromising their structural and functional equilibrium. As early warning tools, cholinesterases (ChEs) are usually used to assess the effects of organophosphate and carbamate pesticides, but are also known to be inhibited by metals. The objectives of this work were to characterise the activity of ChE present in the amphipod Echinogammarus meridionalis and the shrimp Atyaephyra desmarestii and to evaluate the in vivo effects of the metals copper and zinc in their ChE activity. To achieve this, firstly the activity of ChE forms were characterised using different in vitro assays with substrates and selective inhibitors. Then, the in vivo effects of 48 h exposures to increasing concentrations of copper and zinc on ChE activity were determined. The ChE form present in both species was acetylcholinesterase (AChE) since both revealed preference for the acetylthiocholine iodide substrate, total inhibition with eserine, the inhibitor of ChEs, and with 1,5-bis(4-allyldimethylammoniumphenyl)-pentan-3-one dibromide, the specific inhibitor of AChE, and presented insensitivity to iso-OMPA, a specific inhibitor of butyrylcholinesterase. The activity of ChEs was inhibited by zinc exposures in the amphipod species, but was not affected by copper. Exposure to copper and zinc did not affect ChEs activity in the shrimp at the concentrations tested. This work is a relevant contribution as foundation for the use of AChE in freshwater crustaceans in further studies including biomonitoring campaigns in different contamination scenarios.


Subject(s)
Amphipoda/drug effects , Cholinesterases/analysis , Copper/toxicity , Panicum/drug effects , Zinc/toxicity , Acetylthiocholine/analogs & derivatives , Acetylthiocholine/metabolism , Amphipoda/enzymology , Animals , Butyrylcholinesterase/analysis , Butyrylcholinesterase/metabolism , Cholinesterase Inhibitors/pharmacology , Cholinesterases/metabolism , Environmental Monitoring/methods , Panicum/enzymology , Physostigmine/pharmacology , Tetraisopropylpyrophosphamide/pharmacology
5.
Neuropsychopharmacology ; 39(6): 1538-46, 2014 May.
Article in English | MEDLINE | ID: mdl-24407266

ABSTRACT

A new pharmacokinetic approach treating cocaine addiction involves rapidly metabolizing cocaine before it reaches brain reward centers using mutated human butyrylcholinesterase (BChE) or cocaine hydrolase (CocH). Recent work has shown that helper-dependent adenoviral (hdAD) vector-mediated plasma CocH reduced the locomotor-activating effects of cocaine and prevented reinstatement of cocaine-seeking behavior up to 6 months in rats. The present study investigated whether hdAD-CocH could decrease ongoing intravenous cocaine (0.4 mg/kg) self-administration. The hdAD-CocH vector was injected into self-administering rats, and after accumulation of plasma CocH, there was a dramatic reduction in cocaine infusions earned under a fixed ratio 1 schedule of reinforcement that lasted for the length of the study (>2 months). Pretreatment with the selective BChE and CocH inhibitor iso-OMPA (1.5 mg/kg) restored cocaine intake; therefore, the decline in self-administration was likely due to rapid CocH-mediated cocaine metabolism. Direct measurements of cocaine levels in plasma and brain samples taken after the conclusion of behavioral studies provided strong support for this conclusion. Further, rats injected with hdAD-CocH did not experience a deficit in operant responding for drug reinforcement and self-administered methamphetamine (0.05 mg/kg) at control levels. Overall, these outcomes suggest that viral gene transfer can yield plasma CocH levels that effectively diminish long-term cocaine intake and may have potential treatment implications for cocaine-dependent individuals seeking to become and remain abstinent.


Subject(s)
Cocaine-Related Disorders/therapy , Cocaine/metabolism , Genetic Therapy , Hydrolases/genetics , Hydrolases/metabolism , Adenoviridae/genetics , Amphetamine-Related Disorders/enzymology , Amphetamine-Related Disorders/therapy , Animals , Brain/drug effects , Brain/metabolism , Central Nervous System Stimulants/administration & dosage , Cholinesterase Inhibitors/pharmacology , Cocaine/administration & dosage , Cocaine/blood , Cocaine-Related Disorders/enzymology , Conditioning, Operant/drug effects , Conditioning, Operant/physiology , Female , Genetic Vectors , Methamphetamine/administration & dosage , Rats , Rats, Wistar , Reinforcement Schedule , Self Administration , Tetraisopropylpyrophosphamide/pharmacology , Time Factors
6.
Article in English | MEDLINE | ID: mdl-23701992

ABSTRACT

Cholinesterase (ChE, EC 3.1.1.7) activity was investigated in gills and adductor muscle of two bivalve species: Arca noae and Venus verrucosa. The properties of ChEs were investigated using acetylcholine iodide (ASCh), butyrylcholine iodide (BSCh) and propionylcholine iodide (PrSCh) as substrates and eserine, BW254c51 and iso-OMPA as specific inhibitors. The highest level of ChE activity in crude tissue extracts was detected with PrSCh followed by ASCh, while values obtained with BSCh were apparently low, except in A. noae adductor muscle. The enzyme activity in A. noae gills and V. verrucosa gills and adductor muscle was significantly inhibited by BW254c51, but not with iso-OMPA. ChE activity in adductor muscle of A. noae was significantly reduced by both diagnostic inhibitors. The effect of organophosphorous pesticide trichlorfon on ChE activity was investigated in vitro in both species as well as in the gills of mussels Mytilus galloprovincialis. The highest sensitivity of ChE to trichlorfon was observed in A. noae gills and adductor muscle (IC50 1.6×10(-7)M and 1.1×10(-7)M, respectively), followed by M. galloprovincialis gills (IC50 1.0×10(-6)M) and V. verrucosa gills and adductor muscle (IC50 1.7×10(-5)M and 0.9×10(-5)M, respectively). The results of this study suggest the potential of ChE activity measurement in the tissues of A. noae as effective biomarker of OP exposure in marine environment.


Subject(s)
Bivalvia/enzymology , Cholinesterases/metabolism , Pesticides/toxicity , Trichlorfon/toxicity , Acetylcholine , Animals , Choline/analogs & derivatives , Cholinesterase Inhibitors/pharmacology , Gills/drug effects , Gills/enzymology , In Vitro Techniques , Muscles/drug effects , Muscles/enzymology , Species Specificity , Statistics, Nonparametric , Tetraisopropylpyrophosphamide/pharmacology
7.
Article in English | MEDLINE | ID: mdl-21777695

ABSTRACT

Cholinesterase (ChE) activities were characterized in silver European eel, Anguilla anguilla, grown in the brackish lagoon of Comacchio (Italy). All specimens were harvested at the "lavoriero", a traditional eel trapping weir that captures eels while leaving internal waters at the onset of reproductive migration. To our knowledge, no investigation on ChE was reported in silver eels. Therefore a first characterization of enzyme activity in muscle, brain, liver and plasma of silver eel was carried out, in the presence of different substrates, selective inhibitors, and four pesticides representative of the carbamate and organophosphate classes. Brain and white skeletal muscle showed similar ChE activities, 5- and 10-fold higher than those detected in liver and plasma, respectively. Km values of 0.31 and 0.30 mM, and Vmax values of 40.28 and 35.47 nmol min(-1) mg protein(-1) were obtained in brain and muscle ChE, respectively. Acetycholinesterase was the predominant ChE form in all tissues, as concluded by comparing the effects of BW 284c51, iso-OMPA and eserine. ChE activities in brain and muscle were significantly inhibited by in vitro treatment with pesticides, with the following order of potency: carbofuran>carbaryl>chlorpyrifos≥diazinon.


Subject(s)
Brain/enzymology , Cholinesterases/drug effects , Cholinesterases/metabolism , Liver/enzymology , Muscle, Skeletal/enzymology , Pesticides/pharmacology , Anguilla , Animals , Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide/pharmacology , Cholinesterase Inhibitors/pharmacology , Cholinesterases/blood , Kinetics , Physostigmine/pharmacology , Tetraisopropylpyrophosphamide/pharmacology
8.
Pharmacol Res ; 58(5-6): 297-301, 2008.
Article in English | MEDLINE | ID: mdl-18824231

ABSTRACT

Acetylcholinesterase (AChE) inhibitors stimulate gastrointestinal (GI) motility and are potential treatments of conditions associated with inadequate GI motility. The ability of itopride to facilitate neuronally (predominantly cholinergic) mediated contractions of rat isolated stomach, evoked by electrical field stimulation (EFS), has been compared with other cholinesterase inhibitors and with tegaserod, a clinically effective prokinetic and non-selective 5-HT(4) receptor agonist which also facilitates GI cholinergic function. Neostigmine greatly increased EFS-evoked contractions over a narrow concentration range (0.01-1 microM; 754+/-337% facilitation at 1 microM); higher concentrations (1, 3 microM) also increased muscle tension. Donepezil increased EFS-evoked contractions gradually over the full range of concentrations (0.01-10 microM; maximum increase 516+/-20% at 10 microM). Itopride increased the contractions even more gradually, rising to 188+/-84% at 10 microM. The butyrylcholinesterase inhibitor iso-OMPA 0.01-10 microM also increased EFS-evoked contractions, to a maximum of 36+/-5.0% at 10 microM, similar to that caused by tegaserod (35+/-5.2% increase at 1 microM). The effects of tegaserod, but not itopride were inhibited by the 5-HT(4) receptor antagonist SB-204070A 0.3 microM. In rat isolated colon, neostigmine was again the most efficacious, causing a defined maximum increase in EFS-evoked contractions (343+/-82% at 10 microM), without changing muscle tension. Maximum increases caused by donepezil and itopride were, respectively, 57.6+/-20 and 43+/-15% at 10 microM. These data indicate that the abilities of different AChE inhibitors to increase GI cholinergic activity differ markedly. Understanding the reasons is essential if AChE inhibitors are to be optimally developed as GI prokinetics.


Subject(s)
Cholinesterase Inhibitors/pharmacology , Colon/drug effects , Colon/innervation , Parasympathetic Nervous System/drug effects , Stomach/drug effects , Stomach/innervation , Animals , Butyrylcholinesterase/metabolism , Donepezil , Gastrointestinal Agents/pharmacology , Gastrointestinal Motility/drug effects , Indans/pharmacology , Indoles/pharmacology , Male , Neostigmine/pharmacology , Piperidines/pharmacology , Rats , Rats, Sprague-Dawley , Tetraisopropylpyrophosphamide/pharmacology
9.
Xenobiotica ; 38(3): 294-313, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18274958

ABSTRACT

1. The in vitro human plasma activity and liver microsomal metabolism of pyridostigmine bromide (PB), a prophylactic treatment against organophosphate nerve agent attack, N,N-diethyl-m-toluamide (DEET), an insect repellent, and permethrin, a pyrethroid insecticide, either alone or in combination were investigated. 2. The three chemicals disappeared from plasma in the following order: permethrin > PB > DEET. The combined incubation of DEET with either permethrin or PB had no effect on permethrin or PB. Binary incubation with permethrin decreased the metabolism of PB and its disappearance from plasma and binary incubation with PB decreased the metabolism of permethrin and its clearance from plasma. Incubation with PB and/or permethrin shortened the DEET terminal half-life in plasma. These agents behaved similarly when studied in liver microsomal assays. The combined incubation of DEET with PB or permethrin (alone or in combination) diminished DEET metabolism in microsomal systems. 3. The present study evidences that PB and permethrin are metabolized by both human plasma and liver microsomal enzymes and that DEET is mainly metabolized by liver oxidase enzymes. Combined exposure to test chemicals increases their neurotoxicity by impeding the body's ability to eliminate them because of the competition for detoxifying enzymes.


Subject(s)
DEET/blood , DEET/metabolism , Microsomes, Liver/enzymology , Permethrin/blood , Permethrin/metabolism , Pyridostigmine Bromide/blood , Pyridostigmine Bromide/metabolism , Biotransformation/drug effects , Butyrylcholinesterase/metabolism , Cholinesterase Inhibitors/pharmacology , DEET/chemistry , Drug Interactions , Esterases/blood , Half-Life , Humans , Kinetics , Microsomes, Liver/drug effects , Microsomes, Liver/metabolism , Oxidoreductases/metabolism , Permethrin/chemistry , Pyridostigmine Bromide/chemistry , Tetraisopropylpyrophosphamide/pharmacology
10.
Aquat Toxicol ; 84(3): 328-336, 2007 Oct 15.
Article in English | MEDLINE | ID: mdl-17688956

ABSTRACT

Assessment of cholinesterase (ChE) inhibition is widely used as a specific biomarker for evaluating the exposure and effects of non-target organisms to anticholinesterase agents. Cholinesterase and carboxylesterase activities have been measured in larvae of gilthead seabream, Sparus aurata, during the endogenous feeding stage, and ChE was characterized with the aid of diagnostic substrates and inhibitors. The results of the present study showed that whole-body ChE of yolk-sac seabream larvae possesses typical properties of acetylcholinesterase (AChE) with a apparent affinity constant (K(m)) of 0.163+/-0.008 mM and a maximum velocity (V(max)) of 332.7+/-2.8 nmol/min/mg protein. Moreover, sensibility of this enzyme was investigated using the organophosphorus insecticide azinphosmethyl. Static-renewal toxicity tests were conducted over 72 h and larval survival and AChE inhibition were recorded. Mean mortality of seabream larvae increased with increasing concentrations of azinphosmethyl and exposure duration. The estimated 72-h LC50 value to azinphosmethyl was 4.59 microg/l (95% CI=0.46-8.71 microg/l) and inhibition of ChE activity gave an IC50 of 3.04 microg/l (95% CI=2.73-3.31 microg/l). Larvae exposed to azinphosmethyl for 72h showed a 70% inhibition of the whole-body acetylcholinesterase activity at approximately the LC50. In conclusion, the results of the present study suggested that monitoring ChE activity is a valuable tool indicating OP exposure in S. aurata larvae and that acetylthiocholine is the most appropriate substrate for assessing ChE inhibition in this early-life stage of the fish.


Subject(s)
Azinphosmethyl/pharmacology , Cholinesterase Inhibitors/pharmacology , Cholinesterases/metabolism , Insecticides/pharmacology , Sea Bream/metabolism , Animals , Azinphosmethyl/toxicity , Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide/pharmacology , Cholinesterase Inhibitors/toxicity , Inhibitory Concentration 50 , Insecticides/toxicity , Kinetics , Larva , Physostigmine/pharmacology , Substrate Specificity , Tetraisopropylpyrophosphamide/pharmacology , Yolk Sac/drug effects , Yolk Sac/enzymology
11.
Toxicology ; 238(2-3): 157-65, 2007 Sep 05.
Article in English | MEDLINE | ID: mdl-17644233

ABSTRACT

Organophosphorus (OP) pesticides elicit acute toxicity by inhibiting acetylcholinesterase (AChE), the enzyme responsible for inactivating acetylcholine (ACh) at cholinergic synapses. A number of OP toxicants have also been reported to interact directly with muscarinic receptors, in particular the M(2) muscarinic subtype. Parasympathetic innervation to the heart primarily regulates cardiac function by activating M(2) receptors in the sinus node, atrial-ventricular node and conducting tissues. Thus, OP insecticides can potentially influence cardiac function in a receptor-mediated manner indirectly by inhibiting acetylcholinesterase and directly by binding to muscarinic M(2) receptors. Young animals are generally more sensitive than adults to the acute toxicity of OP insecticides and age-related differences in potency of direct binding to muscarinic receptors by some OP toxicants have been reported. We thus compared the effects of the common OP insecticide chlorpyrifos (CPF) on functional signs of toxicity and cardiac cholinesterase (ChE) activity and muscarinic receptor binding in neonatal and adult rats. Dosages were based on acute lethality (i.e., 0.5 and 1x LD(10): neonates, 7.5 and 15 mg/kg; adults, 68 and 136 mg/kg). Dose- and time-related changes in body weight and cholinergic signs of toxicity (involuntary movements) were noted in both age groups. With 1x LD(10), relatively similar maximal reductions in ChE activity (95%) and muscarinic receptor binding (approximately 30%) were noted, but receptor binding reductions appeared earlier in adults and were more prolonged in neonates. In vitro inhibition studies indicated that ChE in neonatal tissues was markedly more sensitive to inhibition by the active metabolite of chlorpyrifos (i.e., chlorpyrifos oxon, CPO) than enzyme in adult tissues (IC(50) values: neonates, 17 nM; adults, 200 nM). Chelation of free calcium with EDTA had relatively little effect on in vitro cholinesterase inhibition, suggesting that differential A-esterase activity was not responsible for the age-related difference in cholinesterase sensitivity between age groups. Pre-incubation of neonatal and adult tissues with selective inhibitors of AChE and butyrylcholinesterase (BChE) indicated that a majority (82-90%) of ChE activity in the heart of both neonates and adults was BChE. The rapid onset (by 4h after dosing) of changes in muscarinic receptor binding in adult heart may be a reflection of the more potent direct binding to muscarinic receptors by chlorpyrifos oxon previously reported in adult tissues. The results suggest that ChE activity (primarily BChE) in neonatal heart may be inherently more sensitive to inhibition by some anticholinesterases and that toxicologically significant binding to muscarinic receptors may be possible with acute chlorpyrifos intoxication, potentially contributing to age-related differences in sensitivity.


Subject(s)
Chlorpyrifos/analogs & derivatives , Cholinesterases/metabolism , Heart/drug effects , Receptors, Muscarinic/metabolism , Administration, Oral , Age Factors , Animals , Animals, Newborn , Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide/pharmacology , Chlorpyrifos/administration & dosage , Chlorpyrifos/toxicity , Female , Heart/physiology , Inhibitory Concentration 50 , Male , Muscarinic Agonists/pharmacology , Myocardium/enzymology , Myocardium/metabolism , Oxotremorine/pharmacology , Protein Binding/drug effects , Rats , Rats, Sprague-Dawley , Tetraisopropylpyrophosphamide/pharmacology , Weight Gain/drug effects , Weight Loss/drug effects
12.
Life Sci ; 80(24-25): 2380-5, 2007 May 30.
Article in English | MEDLINE | ID: mdl-17467011

ABSTRACT

At the neuromuscular junction (NMJ) acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) can hydrolyze acetylcholine (ACh). Released ACh quanta are known to diffuse rapidly across the narrow synaptic cleft and pairs of ACh molecules cooperate to open endplate channels. During their diffusion through the cleft, or after being released from muscle nicotinic ACh receptors (nAChRs), most ACh molecules are hydrolyzed by AChE highly concentrated at the NMJ. Advances in mouse genomics offered new approaches to assess the role of specific cholinesterases involved in synaptic transmission. AChE knockout mice (AChE-KO) provide a valuable tool for examining the complete abolition of AChE activity and the role of BChE. AChE-KO mice live to adulthood, and exhibit an increased sensitivity to BChE inhibitors, suggesting that BChE activity facilitated their survival and compensated for AChE function. Our results show that BChE is present at the endplate region of wild-type and AChE-KO mature muscles. The decay time constant of focally recorded miniature endplate currents was 1.04 +/- 0.06 ms in wild-type junctions and 5.4 ms +/- 0.3 ms in AChE-KO junctions, and remained unaffected by BChE-specific inhibitors, indicating that BChE is not limiting ACh duration on endplate nAChRs. Inhibition of BChE decreased evoked quantal ACh release in AChE-KO NMJs. This reduction in ACh release can explain the greatest sensitivity of AChE-KO mice to BChE inhibitors. BChE is known to be localized in perisynaptic Schwann cells, and our results strongly suggest that BChE's role at the NMJ is to protect nerve terminals from an excess of ACh.


Subject(s)
Acetylcholinesterase/metabolism , Butyrylcholinesterase/metabolism , Synaptic Transmission/physiology , Acetylcholinesterase/genetics , Animals , Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide/pharmacology , Cholinesterase Inhibitors/pharmacology , Electrophysiology , Female , Male , Mice , Mice, Inbred Strains , Mice, Knockout , Microscopy, Electron , Motor Endplate/drug effects , Motor Endplate/metabolism , Motor Endplate/physiology , Muscle, Skeletal/drug effects , Muscle, Skeletal/innervation , Muscle, Skeletal/physiology , Neuromuscular Junction/metabolism , Neuromuscular Junction/physiology , Neuromuscular Junction/ultrastructure , Synaptic Transmission/drug effects , Tetraisopropylpyrophosphamide/pharmacology , Time Factors
13.
Toxicology ; 236(3): 178-89, 2007 Jul 17.
Article in English | MEDLINE | ID: mdl-17532548

ABSTRACT

The aim of this study was to characterize cholinesterase (ChE) activity in Gammarus pulex, an abundant and ecologically relevant species of the European stream environment. Biochemical and pharmacological properties were tested using different substrates (acetylthiocholine iodide, propionylthiocholine iodide and butyrylthiocholine iodide) and selective inhibitors (eserine sulfate, BW284c51 and iso-OMPA). In a second part, the in vitro and in vivo effects of a widely used organophosphorous pesticide, chlorpyrifos, on ChE activity were investigated. The results suggest that G. pulex possess only one ChE which displays the typical properties of an acetylcholinesterase, since: (1) it hydrolyses to the substrate acetylthiocholine at a higher rate than all other tested substrates and (2) it is highly sensitive to eserine sulphate and BW284c51, but not to iso-OMPA. In vitro and in vivo inhibitions were observed for highly different contamination levels, which suggests that bioaccumulation and biotransformation mechanisms are involved. In vivo AChE inhibition was observed at realistic environmental concentrations, with lethal effects appearing at inhibitions higher than 50%. The results of this study show the value of G. pulex as a sentinel organism for environmental assessment.


Subject(s)
Chlorpyrifos/toxicity , Cholinesterase Inhibitors/toxicity , Cholinesterases/metabolism , Crustacea/enzymology , Insecticides/toxicity , Animals , Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide/pharmacology , Biomarkers/metabolism , Cholinesterases/chemistry , Cholinesterases/classification , Crustacea/drug effects , Dose-Response Relationship, Drug , Environmental Monitoring , Iodides/pharmacology , Longevity/drug effects , Physostigmine/pharmacology , Sentinel Surveillance , Substrate Specificity , Tetraisopropylpyrophosphamide/pharmacology , Thiocholine/pharmacology
14.
Life Sci ; 80(24-25): 2375-9, 2007 May 30.
Article in English | MEDLINE | ID: mdl-17459421

ABSTRACT

The expression of a cholinergic system during embryonic development is a widespread phenomenon. However, no precise function could be assigned to it during early pre-neural stages and there are only few studies that document when it precisely starts to be expressed. Here, we examined the expression of cholinergic components in a murine embryonic stem cell line by RT-PCR, histochemistry, and enzyme activity measurements; the acetylcholine (ACh) content was measured by HPLC. We have demonstrated that embryonic stem cells express ACh, acetylcholine receptors, choline acetyltransferase (ChAT), acetyl- and butyryl-cholinesterase (AChE and BChE). Butyryl-cholinesterase (BChE) expression was higher than AChE. The cholinesterase activity was down-regulated by adding specific inhibitors to culture medium. Inhibition of BChE led to a reduction of proliferation. This is the first demonstration that mouse embryonic stem cells express the full molecular equipment of a cholinergic system. Locally produced ACh might function as an intercellular signal, modulating the proliferation of stem cells.


Subject(s)
Choline O-Acetyltransferase/genetics , Cholinesterases/genetics , Embryonic Stem Cells/metabolism , Gene Expression Profiling , Receptors, Cholinergic/genetics , Acetylcholine/metabolism , Acetylcholinesterase/genetics , Acetylcholinesterase/metabolism , Animals , Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide/pharmacology , Butyrylcholinesterase/genetics , Butyrylcholinesterase/metabolism , Cell Line , Cell Proliferation/drug effects , Choline O-Acetyltransferase/metabolism , Cholinesterase Inhibitors , Cholinesterases/metabolism , Embryonic Stem Cells/cytology , Embryonic Stem Cells/drug effects , Mice , Receptors, Cholinergic/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Tetraisopropylpyrophosphamide/pharmacology , Time Factors
15.
Comp Biochem Physiol C Toxicol Pharmacol ; 143(4): 416-21, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16753348

ABSTRACT

Assessment of pollution impact in soil ecosystems has become a priority and interest has grown concerning the use of invertebrates as sentinel organisms. Inhibition of cholinesterase (ChE) activity has a great potential as a biomarker of pesticide exposure, and we evaluated the ChE kinetic parameters in the earthworm Eisenia andrei in the presence of acetylthiocholine (ASCh), proprionylthiocholine (PSCh) and butyrylthiocholine (BSCh). The highest ChE activity was found in the presence of ASCh and PSCh (42.45 and 49.82 nmol min(-1) mg protein(-1), respectively). BSCh was hydrolyzed at a rate of 4.04 nmol min(-1) mg protein(-1), but the time course did not reach a plateau under our experimental conditions. Km values were 0.142+/-0.006 and 0.183+/-0.053 mM for ASCh and PSCh, respectively. ASCh and PSCh hydrolysis were significantly inhibited by eserine (IC50 values were 1.44 x 10(-8) and 1.20 x 10(-8) M, respectively) and by carbaryl (IC50 values of 5.75 x 10(-9) and 4.79 x 10(-9) M). The presence of different ChEs in tissues from E. andrei was assessed by using selective inhibitors for AChE (BW284c51) and BChE (iso-OMPA). BW284c51 strongly reduced ASCh and PSCh hydrolysis and slightly affected that of BSCh, while iso-OMPA was without effect in all cases.


Subject(s)
Cholinesterases/metabolism , Oligochaeta/enzymology , Acetylthiocholine/metabolism , Animals , Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide/pharmacology , Butyrylthiocholine/metabolism , Carbaryl/pharmacology , Cholinesterase Inhibitors/pharmacology , Kinetics , Physostigmine/pharmacology , Soil Pollutants/analysis , Substrate Specificity , Tetraisopropylpyrophosphamide/pharmacology , Thiocholine/analogs & derivatives , Thiocholine/metabolism
16.
Biochimie ; 88(1): 59-68, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16085351

ABSTRACT

We show here that serum of piaussu, a Neotropical characin fish, has the highest butyrylcholinesterase activity so far described for humans and fish. To clarify whether this cholinesterase could protect piaussu against anticholinesterase pesticides by scavenging organophosphates, we purified it 1700-fold, with a yield of 80%. Augmenting concentrations (from 0.01 to 20 mM) of butyrylthiocholine activated it. The pure enzyme was highly inhibited by chlorpyriphos-oxon (ki=10,434x10(6) M-1 min-1) and by the specific butyrylcholinesterase inhibitor, isoOMPA (ki=45.7x10(6) M-1 min-1). Electrophoresis of total serum and 2-D electrophoresis of the purified cholinesterase showed that some enzyme molecules could circulate in piaussu serum as heterogeneously glycosylated dimers. The enzyme's N-terminal sequence was similar to sequences found for butyrylcholinesterase from sera of other vertebrates. Altogether, our data present a novel butyrylcholinesterase with the potential of protecting a fish from poisoning by organophosphates.


Subject(s)
Butyrylcholinesterase/blood , Fishes/blood , Amino Acid Sequence , Animals , Butyrylcholinesterase/isolation & purification , Butyrylcholinesterase/metabolism , Butyrylthiocholine/metabolism , Chlorpyrifos/analogs & derivatives , Chlorpyrifos/pharmacology , Cholinesterase Inhibitors/pharmacology , Electrophoresis, Gel, Two-Dimensional , Electrophoresis, Polyacrylamide Gel , Humans , Molecular Sequence Data , Organophosphate Poisoning , Paraoxon/analogs & derivatives , Paraoxon/pharmacology , Poisoning/prevention & control , Sequence Alignment , Tetraisopropylpyrophosphamide/pharmacology
17.
Ecotoxicol Environ Saf ; 62(3): 341-7, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16216627

ABSTRACT

In recent years biomarkers have been widely used for the assessment of effects and/or exposure to environmental contaminants. One of the most frequently used biomarkers is the inhibition of cholinesterases (ChE), which is a useful indicator of organophosphate and carbamate exposure and/or effects. Recent studies indicated that more than one ChE may be present in tissues of fish and that different forms may vary in their sensitivity to anticholinesterase agents. Cholinesterase activity of the juvenile of the common goby (Pomatoschistus microps), a widespread fish in estuaries of the Atlantic coast of northwestern Europe, was characterized using four substrates (acetylthiocholine iodide, acetyl-beta-metylthiocholine iodide, propionylthiocholine iodide, and S-butyrylthiocholine iodide) and three ChE inhibitors (eserine sulfate, BW284C51, and iso-OMPA) in different tissues of the fish head. In addition, the range of ChE activity that may be considered as "normal" for non-exposed P. microps was determined. The results suggest the presence of two types of ChE in the whole-head homogenate. The present study underscores the relevance of ChE characterization before its use as a biomarker in biomonitoring studies.


Subject(s)
Cholinesterases/metabolism , Environmental Monitoring/methods , Perciformes/metabolism , Animals , Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide/pharmacology , Biomarkers , Brain/enzymology , Cholinesterase Inhibitors/pharmacology , Eye/enzymology , Head , Physostigmine/pharmacology , Tetraisopropylpyrophosphamide/pharmacology
18.
Vet Res Commun ; 27(8): 611-23, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14672450

ABSTRACT

Cholinesterase (ChE) and acid phosphatase (AP) activities, but not alkaline phosphatase activities, were detected in cytosolic and membrane-bound fractions of adult and infective-stage larvae of levamisole-resistant and levamisole-susceptible Haemonchus contortus. In contrast to other gastrointestinal nematodes, the ChE activity was higher in L3 than in adults and, in both cases, was mainly associated with membranes. ChE activity was inhibited by Triton X-100 and was only detected in membrane-bound fractions when the detergent was removed. Differences between resistant and susceptible L3 were observed in the response to inhibitors (cytosolic fraction) and in the enzymatic content (membrane-bound fraction). Phosphatase activity was detected at acidic pH in all fractions, being higher in the adult than in the L3 stage. In the former, most of the enzyme was localized in the membrane-bound fractions, whereas in the latter it was mainly in cytosolic fractions. This difference could be correlated with the activity in the gut. In inhibition assays, a difference between cytosolic fractions from resistant and susceptible adults was observed in their response to 1 mmol/L tartaric acid.


Subject(s)
Acid Phosphatase/metabolism , Alkaline Phosphatase/metabolism , Anthelmintics/pharmacology , Cholinesterases/metabolism , Haemonchus/enzymology , Levamisole/pharmacology , Acid Phosphatase/antagonists & inhibitors , Alkaline Phosphatase/antagonists & inhibitors , Animals , Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide/pharmacology , Cholinesterase Inhibitors/pharmacology , Cytosol/enzymology , Drug Resistance , Haemonchus/growth & development , Larva/enzymology , Octoxynol/pharmacology , Tetraisopropylpyrophosphamide/pharmacology
19.
Eur J Neurosci ; 18(6): 1419-27, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14511322

ABSTRACT

Cholinergic neurotransmission ensures muscle contraction and plays a role in the regulation of respiratory pattern in the brainstem. Inactivation of acetylcholinesterase (AChE) by organophosphates produces respiratory failure but AChE knockout mice survive to adulthood. Respiratory adaptation mechanisms which ensure survival of these mice were examined in vivo by whole body plethysmography and in vitro in the neonatal isolated brainstem preparation. AChE-/- mice presented no AChE activity but unaffected butyrylcholinesterase (BChE) activity. In vivo, bambuterol (50-500 microg/kg s.c.) decreased BChE activity peripherally but not in brain tissue and induced apnea and death in adult and neonate AChE-/- mice without affecting littermate AChE+/+ and +/- animals. In vitro, bath-applied bambuterol (1-100 microm) and tetraisopropylpyrophosphoramide (10-100 microm) decreased BChE activity in the brainstem but did not perturb central respiratory activity recorded from spinal nerve rootlets. In vitro, the cholinergic agonists muscarine (50-100 microm) and nicotine (0.5-10 microm) induced tonic activity in respiratory motoneurons and increased the frequency of inspiratory bursts in AChE+/+ and +/- animals. These effects were greatly attenuated in AChE-/- animals. The results suggest that, in mice lacking AChE, (i) BChE becomes essential for survival peripherally but plays no critical role in central rhythm-generating structures and (ii) a major adaptive mechanism for respiratory survival is the down-regulated response of central respiratory-related neurons and motoneurons to muscarinic and nicotinic agonists.


Subject(s)
Acetylcholinesterase/metabolism , Brain Stem/physiopathology , Respiration , Terbutaline/analogs & derivatives , Acetylcholinesterase/blood , Acetylcholinesterase/deficiency , Acetylcholinesterase/genetics , Action Potentials/drug effects , Animals , Animals, Newborn , Apnea/physiopathology , Brain/drug effects , Brain/enzymology , Bronchodilator Agents/pharmacology , Butyrylcholinesterase/blood , Butyrylcholinesterase/metabolism , Cholinesterase Inhibitors/pharmacology , Dose-Response Relationship, Drug , Female , Genotype , In Vitro Techniques , Male , Mice , Mice, Knockout , Muscarine/pharmacology , Muscarinic Agonists/pharmacology , Muscles/drug effects , Muscles/enzymology , Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Plethysmography/instrumentation , Plethysmography/methods , Pulmonary Ventilation/drug effects , Respiration/drug effects , Terbutaline/pharmacology , Tetraisopropylpyrophosphamide/pharmacology
20.
Urol Res ; 31(3): 223-6, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12736766

ABSTRACT

This study examines the effects of inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) on acetylcholine (ACh)-induced contraction in rat urinary bladder smooth muscle. Neostigmine, a non-selective ChE inhibitor, caused concentration-dependent contractions in rat urinary bladder strips, whereas tetraisopropylpyrophosphoramide (iso-OMPA; a BuChE inhibitor) failed to affect the resting tone of the preparations. Neostigmine (1 microM) markedly augmented the contractile responses to ACh. Although iso-OMPA (10 microM) also potentiated ACh-induced contraction, the effect was less than that evoked by neostigmine. The activities of AChE in rat urinary bladder strips were significantly (P<0.05) higher than those of BuChE. These results indicated that AChE, rather than BuChE, plays an important role in controlling ACh-induced contractions of rat urinary bladder.


Subject(s)
Acetylcholinesterase/physiology , Butyrylcholinesterase/physiology , Muscle Contraction/physiology , Muscle, Smooth/physiology , Urinary Bladder/physiology , Acetylcholinesterase/metabolism , Animals , Butyrylcholinesterase/metabolism , Cholinesterase Inhibitors/pharmacology , In Vitro Techniques , Male , Muscle Contraction/drug effects , Neostigmine/pharmacology , Rats , Rats, Wistar , Tetraisopropylpyrophosphamide/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL